[EN] AZOLE METHYLIDENE CYANIDE DERIVATIVES AND THEIR USE AS PROTEIN KINASE MODULATORS [FR] DERIVES DE CYANURE D'AZOLE METHYLIDENE ET LEUR UTILISATION COMME MODULATEURS DE PROTEINE KINASE
Azole methylidene cyanide derivatives and their use as protein kinase modulators
申请人:Gaillard Pascale
公开号:US20070123530A1
公开(公告)日:2007-05-31
An azole derivative of formula (I)
a medicament that contains the azole derivative of formula (I), a method of treating a disease with the azole derivative of formula (I), and a method of preparing the azole derivative of formula (I).
AZOLE METHYLIDENE CYANIDE DERIVATIVES AND THEIR USE AS PROTEIN KINASE MODULATORS
申请人:Applied Research Systems ARS Holding N.V.
公开号:EP1527070A1
公开(公告)日:2005-05-04
US7465736B2
申请人:——
公开号:US7465736B2
公开(公告)日:2008-12-16
[EN] AZOLE METHYLIDENE CYANIDE DERIVATIVES AND THEIR USE AS PROTEIN KINASE MODULATORS<br/>[FR] DERIVES DE CYANURE D'AZOLE METHYLIDENE ET LEUR UTILISATION COMME MODULATEURS DE PROTEINE KINASE
申请人:APPLIED RESEARCH SYSTEMS
公开号:WO2003106455A1
公开(公告)日:2003-12-24
The present invention is related to azole derivatives notably for use as pharmaceutically active
compounds, as well as to pharmaceutical formulations containing such azole
derivatives. Said azole derivatives are modulators of the protein kinase signalling
pathways, particularly the one involving c-Jun N-terminal kinase and/or Glycogen
Kinase Synthase 3. The present invention is furthermore related to novel azole
derivatives as well as to methods of their preparation. X is O, S or NR0,
with R0 being H or an unsubstituted or substituted C1 -C6
alkyl; A is 2-pyridyl, 3-pyridyl, 4-pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl
or triazinyl group.
[EN] COPPER COMPLEXES FOR TREATMENT OF NEURODEGENERATIVE DISORDERS<br/>[FR] COMPLEXES DE CUIVRE DESTINÉS AU TRAITEMENT D'ÉTATS NEURODÉGÉNÉRATIFS
申请人:ALS THERAPY DEVELOPMENT INST
公开号:WO2022047014A1
公开(公告)日:2022-03-03
The present disclosure relates to copper complexes, pharmaceutical compositions comprising these complexes, chemical processes for preparing these complexes, and their use in the treatment of neurodegenerative disease, e.g., amyotrophic lateral sclerosis (ALS).